Journal article

Gene modifiers of cystic fibrosis lung disease: A systematic review

Shivanthan Shanthikumar, Melanie N Neeland, Richard Saffery, Sarath Ranganathan

Pediatric Pulmonology | WILEY | Published : 2019


BACKGROUND: Lung disease is the major source of morbidity and mortality in cystic fibrosis (CF), with large variability in severity between patients. Although accurate prediction of lung disease severity would be extremely useful, no robust methods exist. Twin and sibling studies have highlighted the importance of non-cystic fibrosis transmembrane conductance regulator (CFTR) genes in determining lung disease severity but how these impact on the severity in CF remains unclear. METHODS: A systematic review was undertaken to answer the question "In patients with CF which non-CFTR genes modify the severity of lung disease?" The method for this systematic review was based upon the "Preferred Rep..

View full abstract